Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5.43M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
103
-
Shares change
-
-1.59M
-
Total reported value, excl. options
-
$457
-
Value change
-
-$520K
-
Number of buys
-
1
-
Number of sells
-
-23
-
Price
-
$4.39
Significant Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q1 2023
27 filings reported holding APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q1 2023.
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103 shares
of 5.43M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Princeton Global Asset Management LLC (100 shares), Quent Capital, LLC (3 shares), NORTHERN TRUST CORP (0 shares), PNC Financial Services Group, Inc. (0 shares), STIFEL FINANCIAL CORP (0 shares), MORGAN STANLEY (0 shares), FEDERATED HERMES, INC. (0 shares), GROUP ONE TRADING, L.P. (0 shares), RENAISSANCE TECHNOLOGIES LLC (0 shares), and STATE STREET CORP (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.